Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection
Conclusion: TLK2 is notably overexpressed in HBV-related HCC and emerges as a promising prognostic biomarker, necessitating further validation.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Gastroschisis Repair | Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer